AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $407,000 | +31.3% | 8,558 | -0.2% | 0.34% | +17.5% |
| Q4 2018 | $310,000 | -43.6% | 8,576 | -4.1% | 0.29% | -34.8% |
| Q3 2018 | $550,000 | -17.5% | 8,941 | -9.5% | 0.45% | -21.6% |
| Q2 2018 | $667,000 | -27.6% | 9,879 | -41.8% | 0.57% | -29.8% |
| Q1 2018 | $921,000 | -10.8% | 16,973 | -1.8% | 0.81% | -5.6% |
| Q4 2017 | $1,033,000 | +25.7% | 17,286 | +2.2% | 0.86% | +19.0% |
| Q3 2017 | $822,000 | -18.5% | 16,906 | -12.0% | 0.72% | -19.8% |
| Q2 2017 | $1,009,000 | +12.2% | 19,204 | -3.1% | 0.90% | +12.7% |
| Q1 2017 | $899,000 | +5.9% | 19,817 | -11.6% | 0.80% | +4.5% |
| Q4 2016 | $849,000 | -12.4% | 22,422 | -12.7% | 0.76% | -15.9% |
| Q3 2016 | $969,000 | +113.0% | 25,681 | -0.6% | 0.91% | +103.1% |
| Q2 2016 | $455,000 | +44.9% | 25,831 | +0.1% | 0.45% | +43.3% |
| Q1 2016 | $314,000 | -50.0% | 25,797 | 0.0% | 0.31% | -45.5% |
| Q4 2015 | $628,000 | +40.5% | 25,797 | +2.4% | 0.57% | +17.9% |
| Q3 2015 | $447,000 | +130.4% | 25,181 | +129.4% | 0.49% | +154.5% |
| Q2 2015 | $194,000 | – | 10,975 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|